1. Integrated Development Stance

KYOTOBIKEN seamlessly integrates all aspects of the vaccine business ― from R&D through manufacturing to marketing. With everything performed in-house, the outcome is efficient sharing among divisions, enabling immediate understanding of the statuses of development progress and workflow, customer feedback, issues and all other pieces of the puzzle. Integrated quality control leads to day-by-day improvements, which ultimately contributes to quality enhancement.

Operational flow enabling supply of unique and high-quality vaccines

• 
• 
• 

• R&D

  Specialists in each field are working on basic research and development of animal vaccines in order to respond to public demand.

• Manufacturing

  All products are manufactured on the most advanced production lines which comply with GMP regulations.

• Quality Control

  Only products that have passed stringent tests in accordance with our quality management standards are permitted to be delivered to market.

• Packaging and Shipment

  During the whole process, all products are kept under optimal storage conditions.

• After-sales Service and Information Provision

  In order to receive input and feedback from customers and respond to their inquiries and needs, we offer seminars and training workshops, together with up-to-date technical information.

• KYOTOBIKEN Animal Disease Inspection Section

  This section carries out inspections in the course of R&D, manufacturing, marketing, and post-marketing surveillance processes, and makes suggestions to customers about vaccination programs, based on results of investigations into disease-causing agents.

2. Original Products Born out of Customer Needs

KYOTOBIKEN stresses the value of visiting farms and other sites where animals and people are congregated. Therein lies the true strength of our vaccines. We have original products such as “KYOTOBIKEN„ BOVINE EPHEMERAL FEVER-IBARAKI DISEASE INACTIVATED VACCINE,BOVINE EPHEMERAL FEVER VACCINE・K-KB

3. Cultivated Unique Know-how and Pursuit of Cutting-edge Technology

For human health, preventive medicines to control not only human diseases but also animal diseases are vital due to the existence of zoonotic diseases. However, spread of diseases in animals due to various viruses and bacteria is a threat to human life. Today, there is an urgent need to conduct R&D aimed at tackling such threats.

In the field of animal health, KYOTOBIKEN conducts R&D in light of trends both in Japan and overseas. Our approach is broad-based, ranging from fundamental research through development of new products and patent applications. By integrating the experience we have gained since our founding in 1948 with cutting-edge technologies, we aim to develop products which are trusted by our customers.

KYOTOBIKEN places paramount importance on contributing to society through development of new products and by publishing research findings.

4. Rigorous GMP Compliance and Quality Control

KYOTOBIKEN manufactures vaccines in clean environments that are fully compliant with the GMP standard for veterinary biological products.

All products are subjected to rigorous examination by the sections in charge of quality control and quality assurance. In accordance with quality control standards based on GMP and Ministerial Ordinances, our process management is carried out by inspecting not only finished products but also ingredients, raw materials, and intermediate products.

The quality of our vaccines is controlled by means of National Assay and a seed lot system. All vaccines that have passed our in-house testing are packed in cartons marked with lot numbers and expiry dates.

5. Constant Verification of Vaccine Efficacy

Our Animal Disease Inspection Section evaluates vaccine efficacy through inspection of field samples collected from vaccinated animals. We analyze the results to determine whether the animals have been properly immunized, if additional vaccination is required, or if another approach is called for.

Our customers appreciate our professional advice based on the test results obtained through measurement of antibody titer, isolation of pathogens, genetic testing, etc.

Test results and customer feedback obtained from those processes are sent to the R&D section, and utilized for improvement of existing products and development of new lines.